Efficacy of Panobinostat for the Treatment of Multiple Myeloma.

J Oncol · 2020 · PMC7201625 · PMID 32411240

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was a trend towards superior survival for patients that received panobinostat that was sustained in the final overall survival analysis of this trial but did not reach statistical significance [ 73 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.